Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:28:02.378Z.
Calculation as of: 2026-10-06T19:28:02.378Z.
Quote observation: 2026-10-06T19:25:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3747b4faccdf63e20ad288f6e4ea1c731bb156956f174f9644dca84b64e32f29
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-08-03.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
43.52x
EV/EBITDA RATIO AVG 3Y
15.65x
EV/EBITDA RATIO AVG 5Y
16.40x
EV/EBITDA RATIO AVG 10Y
17.18x
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Supernus Pharmaceuticals, Inc.
Market Cap
$2.46B
EV/EBITDA Ratio
N/A
TTM Avg
43.52x
3Y Avg
15.65x
5Y Avg
16.40x
Market Cap
$2.42B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.52B
EV/EBITDA Ratio
N/A
TTM Avg
3.68x
3Y Avg
3.68x
5Y Avg
3.68x
Market Cap
$2.40B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.57B
EV/EBITDA Ratio
N/A
TTM Avg
70.45x
3Y Avg
91.30x
5Y Avg
141.66x
Market Cap
$2.35B
EV/EBITDA Ratio
10.68x
TTM Avg
16.44x
3Y Avg
40.11x
5Y Avg
40.11x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Supernus Pharmaceuticals, Inc. (SUPN) | $2.46B | N/A | 43.52x | 15.65x | 16.40x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.42B | N/A | N/A | N/A | N/A |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.52B | N/A | 3.68x | 3.68x | 3.68x |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | N/A | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.38B | N/A | N/A | N/A | N/A |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | N/A | 70.45x | 91.30x | 141.66x |
| ADMA Biologics, Inc. (ADMA)vs › | $2.35B | 10.68x | 16.44x | 40.11x | 40.11x |
| Beam Therapeutics Inc. (BEAM)vs › | $2.59B | N/A | N/A | N/A | N/A |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.33B | N/A | N/A | N/A | N/A |
| UFP Technologies, Inc. (UFPT)vs › | $2.33B | 20.45x | 17.29x | 21.88x | 20.47x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-08-03 | 45.09x |
| 2026-07-31 | 43.67x |
| 2026-07-30 | 44.69x |
| 2026-07-29 | 45.68x |
| 2026-07-28 | 46.89x |
| 2026-07-27 | 46.11x |
| 2026-07-24 | 45.30x |
| 2026-07-23 | 46.33x |
| 2026-07-22 | 46.07x |
| 2026-07-21 | 47.03x |
| 2026-07-20 | 46.56x |
| 2026-07-17 | 47.21x |
| 2026-07-16 | 47.38x |
| 2026-07-15 | 46.89x |
| 2026-07-14 | 45.78x |
| 2026-07-13 | 46.49x |
| 2026-07-10 | 47.64x |
| 2026-07-09 | 47.94x |
| 2026-07-08 | 49.69x |
| 2026-07-07 | 47.10x |
| 2026-07-06 | 46.38x |
| 2026-07-02 | 47.22x |
| 2026-07-01 | 46.55x |
| 2026-06-30 | 45.62x |
| 2026-06-29 | 45.92x |
| 2026-06-26 | 45.96x |
| 2026-06-25 | 43.80x |
| 2026-06-24 | 44.20x |
| 2026-06-23 | 43.52x |
| 2026-06-22 | 43.52x |
| 2026-06-18 | 43.41x |
| 2026-06-17 | 42.58x |
| 2026-06-16 | 42.58x |
| 2026-06-15 | 42.87x |
| 2026-06-12 | 43.44x |
| 2026-06-11 | 44.63x |
| 2026-06-10 | 44.15x |
| 2026-06-09 | 44.74x |
| 2026-06-08 | 43.52x |
| 2026-06-05 | 43.80x |
| 2026-06-04 | 43.75x |
| 2026-06-03 | 43.06x |
| 2026-06-02 | 43.09x |
| 2026-06-01 | 43.81x |
| 2026-05-29 | 45.28x |
| 2026-05-28 | 45.97x |
| 2026-05-27 | 45.76x |
| 2026-05-26 | 46.93x |
| 2026-05-22 | 47.38x |
| 2026-05-21 | 48.60x |
| 2026-05-20 | 47.88x |
| 2026-05-19 | 46.77x |
| 2026-05-18 | 47.51x |
| 2026-05-15 | 48.65x |
| 2026-05-14 | 50.48x |
| 2026-05-13 | 50.65x |
| 2026-05-12 | 49.79x |
| 2026-05-11 | 48.59x |
| 2026-05-08 | 50.82x |
| 2026-05-07 | 51.60x |
| 2026-05-06 | 50.74x |
| 2026-05-05 | 58.11x |
| 2026-05-04 | 57.42x |
| 2026-05-01 | 56.47x |
| 2026-04-30 | 56.66x |
| 2026-04-29 | 57.33x |
| 2026-04-28 | 57.50x |
| 2026-04-27 | 58.44x |
| 2026-04-24 | 58.80x |
| 2026-04-23 | 59.57x |
| 2026-04-22 | 59.45x |
| 2026-04-21 | 58.02x |
| 2026-04-20 | 60.62x |
| 2026-04-17 | 60.79x |
| 2026-04-16 | 58.14x |
| 2026-04-15 | 59.02x |
| 2026-04-14 | 59.23x |
| 2026-04-13 | 59.03x |
| 2026-04-10 | 59.92x |
| 2026-04-09 | 60.92x |
| 2026-04-08 | 61.06x |
| 2026-04-07 | 60.26x |
| 2026-04-06 | 59.75x |
| 2026-04-02 | 59.68x |
| 2026-04-01 | 60.85x |
| 2026-03-31 | 61.15x |
| 2026-03-30 | 58.30x |
| 2026-03-27 | 58.51x |
| 2026-03-26 | 60.07x |
| 2026-03-25 | 59.17x |
| 2026-03-24 | 58.34x |
| 2026-03-23 | 58.18x |
| 2026-03-20 | 56.36x |
| 2026-03-19 | 57.68x |
| 2026-03-18 | 58.23x |
| 2026-03-17 | 60.09x |
| 2026-03-16 | 59.35x |
| 2026-03-13 | 58.98x |
| 2026-03-12 | 59.65x |
| 2026-03-11 | 63.02x |
| 2026-03-10 | 63.57x |
| 2026-03-09 | 64.18x |
| 2026-03-06 | 63.81x |
| 2026-03-05 | 64.30x |
| 2026-03-04 | 65.90x |
| 2026-03-03 | 64.65x |
| 2026-03-02 | 62.05x |
| 2026-02-27 | 61.63x |
| 2026-02-26 | 62.82x |
| 2026-02-25 | 63.48x |
| 2026-02-24 | 59.96x |
| 2026-02-23 | 56.91x |
| 2026-02-20 | 57.11x |
| 2026-02-19 | 57.68x |
| 2026-02-18 | 56.34x |
| 2026-02-17 | 58.00x |
| 2026-02-13 | 57.09x |
| 2026-02-12 | 55.93x |
| 2026-02-11 | 57.67x |
| 2026-02-10 | 57.49x |
| 2026-02-09 | 57.63x |
| 2026-02-06 | 58.03x |
| 2026-02-05 | 55.37x |
| 2026-02-04 | 55.03x |
| 2026-02-03 | 54.24x |
| 2026-02-02 | 54.68x |
| 2026-01-30 | 53.96x |
| 2026-01-29 | 55.01x |
| 2026-01-28 | 54.87x |
| 2026-01-27 | 55.45x |
| 2026-01-26 | 55.13x |
| 2026-01-23 | 54.07x |
| 2026-01-22 | 55.06x |
| 2026-01-21 | 55.55x |
| 2026-01-20 | 55.90x |
| 2026-01-16 | 56.11x |
| 2026-01-15 | 56.41x |
| 2026-01-14 | 58.21x |
| 2026-01-13 | 57.80x |
| 2026-01-12 | 57.70x |
| 2026-01-09 | 57.40x |
| 2026-01-08 | 57.47x |
| 2026-01-07 | 57.56x |
| 2026-01-06 | 55.24x |
| 2026-01-05 | 55.41x |
| 2026-01-02 | 55.49x |
| 2025-12-31 | 55.76x |
| 2025-12-30 | 55.98x |
| 2025-12-29 | 57.57x |
| 2025-12-26 | 57.94x |
| 2025-12-24 | 58.17x |
| 2025-12-23 | 58.10x |
| 2025-12-22 | 57.86x |
| 2025-12-19 | 57.84x |
| 2025-12-18 | 55.27x |
| 2025-12-17 | 54.65x |
| 2025-12-16 | 54.15x |
| 2025-12-15 | 52.93x |
| 2025-12-12 | 52.79x |
| 2025-12-11 | 52.03x |
| 2025-12-10 | 51.63x |
| 2025-12-09 | 50.76x |
| 2025-12-08 | 52.79x |
| 2025-12-05 | 51.07x |
| 2025-12-04 | 50.39x |
| 2025-12-03 | 49.99x |
| 2025-12-02 | 49.24x |
| 2025-12-01 | 49.92x |
| 2025-11-28 | 50.96x |
| 2025-11-26 | 51.74x |
| 2025-11-25 | 51.53x |
| 2025-11-24 | 50.45x |
| 2025-11-21 | 50.65x |
| 2025-11-20 | 50.03x |
| 2025-11-19 | 51.09x |
| 2025-11-18 | 50.15x |
| 2025-11-17 | 50.38x |
| 2025-11-14 | 50.27x |
| 2025-11-13 | 49.62x |
| 2025-11-12 | 49.83x |
| 2025-11-11 | 51.57x |
| 2025-11-10 | 50.74x |
| 2025-11-07 | 51.46x |
| 2025-11-06 | 17.71x |
| 2025-11-05 | 17.65x |
| 2025-11-04 | 21.51x |
| 2025-11-03 | 21.01x |
| 2025-10-31 | 20.78x |
| 2025-10-30 | 21.32x |
| 2025-10-29 | 21.00x |
| 2025-10-28 | 20.02x |
| 2025-10-27 | 19.84x |
| 2025-10-24 | 19.88x |
| 2025-10-23 | 19.57x |
| 2025-10-22 | 19.04x |
| 2025-10-21 | 19.04x |
| 2025-10-20 | 19.40x |
| 2025-10-17 | 18.84x |
| 2025-10-16 | 18.68x |
| 2025-10-15 | 18.49x |
| 2025-10-14 | 18.47x |
| 2025-10-13 | 18.14x |
| 2025-10-10 | 18.39x |
| 2025-10-09 | 18.58x |
| 2025-10-08 | 17.99x |
| 2025-10-07 | 18.02x |
| 2025-10-06 | 18.12x |
| 2025-10-03 | 18.13x |
| 2025-10-02 | 17.98x |
| 2025-10-01 | 18.01x |
| 2025-09-30 | 17.91x |
| 2025-09-29 | 17.84x |
| 2025-09-26 | 17.61x |
| 2025-09-25 | 17.67x |
| 2025-09-24 | 17.64x |
| 2025-09-23 | 17.54x |
| 2025-09-22 | 17.59x |
| 2025-09-19 | 17.23x |
| 2025-09-18 | 17.26x |
| 2025-09-17 | 16.74x |
| 2025-09-16 | 16.43x |
| 2025-09-15 | 16.43x |
| 2025-09-12 | 17.00x |
| 2025-09-11 | 17.47x |
| 2025-09-10 | 17.29x |
| 2025-09-09 | 17.22x |
| 2025-09-08 | 17.14x |
| 2025-09-05 | 17.21x |
| 2025-09-04 | 16.99x |
| 2025-09-03 | 16.79x |
| 2025-09-02 | 16.64x |
| 2025-08-29 | 16.87x |
| 2025-08-28 | 16.97x |
| 2025-08-27 | 16.85x |
| 2025-08-26 | 16.55x |
| 2025-08-25 | 16.60x |
| 2025-08-22 | 16.77x |
| 2025-08-21 | 16.16x |
| 2025-08-20 | 15.91x |
| 2025-08-19 | 15.65x |
| 2025-08-18 | 16.03x |
| 2025-08-15 | 15.92x |
| 2025-08-14 | 15.71x |
| 2025-08-13 | 15.90x |
| 2025-08-12 | 15.35x |
| 2025-08-11 | 15.09x |
| 2025-08-08 | 15.35x |
| 2025-08-07 | 15.44x |
| 2025-08-06 | 15.82x |
| 2025-08-05 | 13.02x |
| 2025-08-04 | 12.85x |
| 2025-08-01 | 12.29x |
| 2025-07-31 | 12.14x |
| 2025-07-30 | 11.59x |
| 2025-07-29 | 11.55x |
| 2025-07-28 | 11.53x |
| 2025-07-25 | 11.59x |
| 2025-07-24 | 11.33x |
| 2025-07-23 | 11.37x |
| 2025-07-22 | 11.26x |
Showing the most recent 260 of 2,945 data points. The chart above shows the full history.
